 | ||||||
| back | ||||||
| NEWS | ||||||
| Fresenius may back out of Akorn deal if probe finds breaches BAD HOMBURG, Germany, Feb 27 (Reuters) - Fresenius may back out of the planned acquisition of Akorn if its probe into data integrity at the U.S. maker of liquid generic drugs yields evidence of wrongdoing, the German healthcare group's chief executive said. "If the allegations prove to be conclusive ...
| ||||||
| See more results | Edit this alert | ||||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
No comments:
Post a Comment